Cargando…
The role of berberine in Covid-19: potential adjunct therapy
Coronavirus disease 2019 (Covid-19) is a global diastrophic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Covid-19 leads to inflammatory, immunological, and oxidative changes, by which SARS-CoV-2 leads to endothelial dysfunction (ED), acute lung injury (ALI), acute...
Autores principales: | Babalghith, Ahmad O., Al-kuraishy, Hayder M., Al-Gareeb, Ali I., De Waard, Michel, Al-Hamash, Sadiq Mohammed, Jean-Marc, Sabatier, Negm, Walaa A., Batiha, Gaber El-Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526677/ https://www.ncbi.nlm.nih.gov/pubmed/36183284 http://dx.doi.org/10.1007/s10787-022-01080-1 |
Ejemplares similares
-
Montelukast and Acute Coronary Syndrome: The Endowed Drug
por: Alomair, Basil Mohammed, et al.
Publicado: (2022) -
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
por: Babalghith, Ahmad O., et al.
Publicado: (2022) -
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
por: Batiha, Gaber El-Saber, et al.
Publicado: (2023) -
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)